BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry
BOULDER, Colo., Jan. 22, 2015 /PRNewswire/ -- BiOptix is pleased to announce the appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry. Scott joins the company after previous scientific leadership positions at Takeda Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of his nearly 20 year career in therapeutics discovery and development.
"Scott is a nationally recognized thought leader in the biosensor field and particularly in the biophysical characterization of molecular interactions," commented Rick Whitcomb, President and CEO of BiOptix. "It is a testament to BiOptix' future prospects to be able to attract someone of Scott's caliber. With the addition of Scott to our leadership team, we are poised to add significantly more value to our SPR instrument platform, and this in turn will contribute to making our customers in drug discovery more successful," continued Whitcomb.
"I am excited to join BiOptix, a company on the forefront of biosensor technology. I look forward to working with our scientific and engineering teams to enhance the biophysical characterization of molecular interactions – which will aid in improving the drug discovery paradigm," said Dr. Klakamp.
About BiOptix
BiOptix Diagnostics is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures, Remeditex and Rusnano. BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at: www.bioptix.com
BiOptix: Kinetics with Confidence.
SOURCE BiOptix
Share this article